POLATUZUMAB VEDOTIN

10202 reported adverse events

These side effects are most commonly reported by patients taking POLATUZUMAB VEDOTIN:

# Side effect Count
0 DISEASE PROGRESSION 2064
1 OFF LABEL USE 1398
2 DEATH 801
3 NEUTROPENIA 642
4 ANAEMIA 577
5 COVID-19 549
6 FEBRILE NEUTROPENIA 549
7 CYTOKINE RELEASE SYNDROME 542
8 PYREXIA 531
9 DRUG INEFFECTIVE 503
See all common reactions for POLATUZUMAB VEDOTIN

POLATUZUMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 391 0.1772
1 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 114 0.1204
2 LYMPHOMA TRANSFORMATION 40 0.1111
3 DIFFUSE LARGE B-CELL LYMPHOMA 428 0.0555
4 FOLLICULAR LYMPHOMA 45 0.0511
5 CYTOMEGALOVIRUS INFECTION REACTIVATION 133 0.0301
6 CYTOKINE RELEASE SYNDROME 542 0.0270
7 BLOOD LACTATE DEHYDROGENASE INCREASED 419 0.0264
8 LYMPHOMA 383 0.0248
9 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 127 0.0214
See all enriched reactions for POLATUZUMAB VEDOTIN